Unknown

Dataset Information

0

Reprogramming to pluripotency can conceal somatic cell chromosomal instability.


ABSTRACT: The discovery that somatic cells are reprogrammable to pluripotency by ectopic expression of a small subset of transcription factors has created great potential for the development of broadly applicable stem-cell-based therapies. One of the concerns regarding the safe use of induced pluripotent stem cells (iPSCs) in therapeutic applications is loss of genomic integrity, a hallmark of various human conditions and diseases, including cancer. Structural chromosome defects such as short telomeres and double-strand breaks are known to limit reprogramming of somatic cells into iPSCs, but whether defects that cause whole-chromosome instability (W-CIN) preclude reprogramming is unknown. Here we demonstrate, using aneuploidy-prone mouse embryonic fibroblasts (MEFs) in which chromosome missegregation is driven by BubR1 or RanBP2 insufficiency, that W-CIN is not a barrier to reprogramming. Unexpectedly, the two W-CIN defects had contrasting effects on iPSC genomic integrity, with BubR1 hypomorphic MEFs almost exclusively yielding aneuploid iPSC clones and RanBP2 hypomorphic MEFs karyotypically normal iPSC clones. Moreover, BubR1-insufficient iPSC clones were karyotypically unstable, whereas RanBP2-insufficient iPSC clones were rather stable. These findings suggest that aneuploid cells can be selected for or against during reprogramming depending on the W-CIN gene defect and present the novel concept that somatic cell W-CIN can be concealed in the pluripotent state. Thus, karyotypic analysis of somatic cells of origin in addition to iPSC lines is necessary for safe application of reprogramming technology.

SUBMITTER: Hamada M 

PROVIDER: S-EPMC3431347 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

Reprogramming to pluripotency can conceal somatic cell chromosomal instability.

Hamada Masakazu M   Malureanu Liviu A LA   Wijshake Tobias T   Zhou Wei W   van Deursen Jan M JM  

PLoS genetics 20120830 8


The discovery that somatic cells are reprogrammable to pluripotency by ectopic expression of a small subset of transcription factors has created great potential for the development of broadly applicable stem-cell-based therapies. One of the concerns regarding the safe use of induced pluripotent stem cells (iPSCs) in therapeutic applications is loss of genomic integrity, a hallmark of various human conditions and diseases, including cancer. Structural chromosome defects such as short telomeres an  ...[more]

Similar Datasets

| S-EPMC4510695 | biostudies-literature
| S-EPMC3874029 | biostudies-literature
| S-EPMC4955287 | biostudies-literature
| S-EPMC4427539 | biostudies-literature
| S-EPMC4500825 | biostudies-literature
| S-EPMC5425614 | biostudies-literature
| S-EPMC5548918 | biostudies-literature
| S-EPMC8348611 | biostudies-literature
| S-EPMC10446497 | biostudies-literature
| S-EPMC3128971 | biostudies-literature